Surita Parashar, PhD, Health Sciences

Vancouver has an international reputation as one of the healthiest cities in the worldfor those who can afford it. Dr. Surita Parashar is helping prevent those who can’t from falling through the cracks.

Parashar is a Postdoctoral Fellow at the BC Centre for Excellence in HIV/AIDS (BCCfE), a world leader in HIV/AIDS research, treatment, and education. She completed a PhD in Health Science at SFU in 2014, receiving the Dean’s Convocation Medal for her exceptional academic performance.

Parashar is part of research team that is evaluating the impact of a supportive housing model on the health of HIV-positive residents at risk of homelessness. At Home At Howe (AHAH) is being led in collaboration with the McLaren Housing Society of BC.

“The knowledge generated through AHAH will help policy makers and service providers understand how we can better support the housing needs of people living with HIV and may have implications beyond this community,” says Parashar.

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below